Glover Stephen C. 4
4 · Ambrx Biopharma Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
Glover Stephen C.
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-18+17,500→ 17,500 totalExercise: $1.97Exp: 2033-05-18→ Ordinary Shares (17,500 underlying) - Award
Ordinary Shares
2023-06-07+85,000→ 85,000 total - Award
Stock Option (right to buy)
2023-06-07+40,000→ 40,000 totalExercise: $1.96Exp: 2033-06-07→ Ordinary Shares (40,000 underlying)
Footnotes (5)
- [F1]The Ordinary Shares of the Issuer may be represented by the Issuer's American Depositary Shares ("ADSs"). Each ADS represents seven (7) Ordinary Shares of the Issuer.
- [F2]Represents grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest as follows: on the earlier of (i) the one year anniversary of the date of grant and (ii) the day before the next annual general meeting.
- [F3]The exercise price of the options is equal to the fair market value per ordinary share on the grant date based on the trading price of the ADS.
- [F4]The options vest on June 7, 2024.
- [F5]The options vested on June 6, 2023.